Skip to main content
Clinical Trials/NL-OMON47122
NL-OMON47122
Completed
Not Applicable

Treatment of atrial fibrillation in patients with high sympathetic activity by pulmonary vein isolation in combination with renal denervation or pulmonary vein isolation only; an international randomized, controlled trial. - ASAF trial

Isala Klinieken0 sites100 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypertensie en signalen van sympathische overactiviteit
Sponsor
Isala Klinieken
Enrollment
100
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Isala Klinieken

Eligibility Criteria

Inclusion Criteria

  • The patient falls within the target group resistent hypertension or sympathic overdrive
  • Patient is an acceptable candidate for renal denervation treatment
  • Patient is \< 75 year of age

Exclusion Criteria

  • Contraindication to chronic anticoagulation therapy or heparin
  • Previous left heart ablation procedure for AF
  • Acute coronary syndrome, cardiac surgery, PCI or stroke within 3 months prior to enrolment
  • Renal artery stenosis \>50% of the arterial lumen, or renal artery lumen \<\=3 mm

Outcomes

Primary Outcomes

Not specified

Similar Trials